Articles From: Petron Energy II, Inc. Reports on Production on its Texas Wells to Pfizer Declares 26-Cent Third-Quarter 2014 Dividend


DALLAS, Texas, July 17, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Petron Energy II, Inc. ("Petron II" or the "Company") (OTCBB:PEIID) Petron Energy II, Inc. reports on Production on its Texas wells.
Sign-up for Petron Energy II, Inc. Reports on Production on its Texas Wells investment picks
2014/9/4
By Cris Larano MANILA--Petron Corp.
Sign-up for Petron Plans to Raise Up to PHP10 Billion Via Sale of Preferred Shares investment picks
2014/8/4
LAFAYETTE, La.
Sign-up for PetroQuest Energy Announces Second Quarter Results And Updates Operations investment picks
2014/7/14
LAFAYETTE, La.
Sign-up for PetroQuest Energy, Inc. Invites You To Join Its Second Quarter Earnings 2014 Conference Call investment picks
Petrowest Announces Increase to Revolving Credit Facility Canada NewsWire CALGARY , Aug.
Sign-up for Petrowest Announces Increase to Revolving Credit Facility investment picks
Petrowest Announces Officer Appointments Canada NewsWire CALGARY , Aug.
Sign-up for Petrowest Announces Officer Appointments investment picks
Petrowest Corporation Announces $20 Million Bought Deal Financing and Agreements for Two Acquisitions Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ./ CALGARY , Aug.
Sign-up for Petrowest Corporation Announces $20 Million Bought Deal Financing and Agreements for Two Acquisitions investment picks
Petrowest Corporation Announces Retirement of Vice President, Corporate Affairs Canada NewsWire CALGARY , July 3, 2014 /CNW/ - Petrowest Corporation (PRW: TMX) announced today that Ian Hogg has decided to retire effective June 30, 2014 .
Sign-up for Petrowest Corporation Announces Retirement of Vice President, Corporate Affairs investment picks
PetSmart, Inc .
Sign-up for PetSmart Announces Second Quarter 2014 Results investment picks
Gather the furry, scaly and fluffy around the Halloween cauldron this year to enjoy hundreds of new, exclusive apparel, toys and treats from PetSmart ® (NASDAQ: PETM). From the first Halloween costumes for bearded dragons to an expanded line of guinea pig costumes to clever character costumes for dogs and cats, PetSmart inspires spooky fun for all pets.
Sign-up for PetSmart Creates Halloween Howls and Tail Wags with Frightfully Delightful Products and Services investment picks
PetSmart, Inc. (NASDAQ: PETM) declared a quarterly common stock cash dividend of nineteen and one-half cents ($0.195) per share.
Sign-up for PetSmart Declares Quarterly Cash Dividend investment picks
PetSmart, Inc .
Sign-up for PetSmart Exploring Strategic Alternatives to Maximize Shareholder Value investment picks
2014/9/8
PetSmart’s 53,000 associates across the United States, Canada and Puerto Rico are working together this week to give back during the company’s first-ever enterprise-wide week of volunteering.
Sign-up for PetSmart Launches CommUNITY Week Across North America investment picks
2014/8/19
Sign-up for PetSmart reports higher profit, sales investment picks
By Anna Prior PetSmart Inc. said its board has been reviewing potential changes to the pet-supply retailer's capital structure, including returning capital to shareholders, amid activist pressure.
Sign-up for PetSmart reviews capital structure amid activist pressure investment picks
2014/8/25
PetSmart, Inc. has partnered with the City of Sacramento to bring a portable, pop-up dog park to Sacramento.
Sign-up for PetSmart Unleashes Its One-of-a-Kind Pop-Up Park (P.U.P.) in Sacramento investment picks
PetSmart, Inc. (NASDAQ: PETM ) will release its results for the second quarter 2014 before market open on Wednesday, August 20, 2014.
Sign-up for PetSmart, Inc. to Host Second Quarter 2014 Earnings Conference Call investment picks
THE WOODLANDS, Texas , July 3, 2014 /PRNewswire/ -- CB&I (NYSE:CBI) today announced Lasse Petterson , who announced his retirement in December 2013 as Executive Vice President and Chief Operating Officer, has fulfilled his remaining obligations to the Company effective June 5, 2014 .
Sign-up for Petterson Retirement investment picks
2014/7/30
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Earnings reports were high on the agenda in Europe on Wednesday, moving shares of prominent companies such as Peugeot SA, Airbus Group NV and Barclays PLC.
Sign-up for Peugeot, Barclays among major European movers after earnings investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0967768001&sourceType=1 http://www.ccnmatthews.com/logos/20111129-peyto_200.jpg CALGARY, ALBERTA --
Sign-up for Peyto Exploration & Development Corp. Confirms Dividends for October 15, 2014 investment picks
2014/7/29
SAN DIEGO , July 29, 2014 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share.
Sign-up for Pfenex Announces Closing of Initial Public Offering investment picks
2014/8/29
SAN DIEGO , Aug.
Sign-up for Pfenex Reports Second Quarter 2014 Results and Provides Business Update investment picks
Pfizer Inc. (NYSE:PFE) and Cellectis (Paris:ALCLS) today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
Sign-up for Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration investment picks
Pfizer Inc. (NYSE:PFE) and Merck & Co.
Sign-up for Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen investment picks
Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) announced today that the U.S. Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase alfa) for injection for pediatric patients.
Sign-up for Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease investment picks
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 through 25 year olds.
Sign-up for Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine investment picks
Pfizer Inc. (NYSE:PFE) today announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX ® Coagulation Factor IX (Recombinant) 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B.
Sign-up for Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B investment picks
Pfizer Inc. today announced it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for palbociclib.
Sign-up for Pfizer Announces Submission of Palbociclib New Drug Application to the FDA investment picks
2014/6/26
The board of directors of Pfizer Inc. today declared a 26-cent third-quarter 2014 dividend on the company’s common stock, payable September 3, 2014, to shareholders of record at the close of business on August 1, 2014.
Sign-up for Pfizer Declares 26-Cent Third-Quarter 2014 Dividend investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Petron Energy II, Inc. Reports on Production on its Texas Wells to Pfizer Declares 26-Cent Third-Quarter 2014 Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices